This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hartmann, R.W.; Ehmer, P.B.; Haidar, S.; Hector, M.; Jose, J.; Klein, C.D.; Seidel, S.B.; Sergejew, T.F.; Wachall, B.G.; WÄchter, G.A.; Zhuang, Y.: Inhibition of CYP 17, a new strategy for the treatment of prostata cancer. Arch. Pharmacol, 335, 119–128 (2002)
Haidar, S.; Klein, C.D.; Hartmann, R.W.: Synthesis and evaluation of steroidal hydroxamic acids as inhibitors of P450 17 (1 α-hydroxylase/C17-20 lyase). Arch. Pharmacol., 334, 138–140 (2001)
Recanatini, M.; Bisi, A.; Cavalli, A.; Belluti, F.; Gobbi, S.; Rampa, A.; Valenti, P.; Palzer, M.; Palusczak, A.; Hartmann, R.W.: A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase. J. Med. Chem., 44, 672–680 (2001)
Hartmann, R.W.; Hector, M.; Haidar, S.; Ehmer, P.B.; Reichert, W.; Jose, J.: Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17α-hydroxylase/C17-20-lyase) and 5α-reductase types 1 and 2. J. Med. Chem., 43, 4266–4277 (2000)
Njar, V.C.; Brodie, A.M.: Inhibitors of 17α-hydroxylase/17,20-lyase (CYP17): potential agents for the treatment of prostate cancer. Curr. Pharm. Des., 5, 163–180. (1999)
Auchus, R.J.; Miller, W.L.: Molecular modeling of human P450cl7 (17α-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol. Endocrinol, 13, 1169–1182 (1999)
Brock, B.J.; Waterman, M.R.: The use of random chimeragenesis to study structure/function properties of rat and human P450cl7. Arch. Biochem. Biophys., 373, 401–408 (2000)
Njar, V.C.; Kato, K.; Nnane, I.P.; Grigoryev, D.N.; Long, B.J.; Brodie, A.M.: Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 α-hydroxylase-C17,20-lyase (P450(17) α): potential agents for the treatment of prostate cancer. J. Med. Chem., 41, 902–912 (1998)
Bahshwan, S.A.; Owen, C.P.; Nicholls, P.J.; Smith, H.J.; Ahmadi, M.: Some 1[(benzofuran-2-yl)methyl]imidazoles as inhibitors of 17α-hydroxylase: 17,20-lyase (P450 17) and their specificity patterns. J. Pharm. Pharmacol., 50, 1109–1116 (1998)
Beaudoin, C.; Lavallee, B.; Tremblay, Y.; Hu, D.W.; Breton, R.; De Launoit, Y.; Belanger, A.: Modulation of 17 α-hydroxylase/17,20-lyase activity of guinea pig cytochrome P450cl7 by site-directed mutagenesis. DNA Cell Biol., 17, 707–715 (1998)
Zhuang, Y.; Zapp, J.; Hartmann, R.W.: Synthesis of Zand E-l-methyl-2-(lhydroximinoethyl)-6-methoxy-3,4-dihydronaphthalene and evaluation as inhibitors of 17 α-hydroxylase-C17,20-lyase (P450 17). Arch. Pharmacol., 330, 359–361 (1997)
Njar, V.C.; Klus, G.T.; Johnson, H.H.; Brodie, A.M.: Synthesis of novel 21trifluoropregnane steroids: inhibitors of 17α-hydroxylase/17,20-lyase (17 αlyase). Steroids, 62, 468–473 (1997)
Cloutier, M.; Fleury, A.; Courtemanche, J.; Ducharme, L.; Mason, J.I.; Lehoux, J.G.: Characterization of the adrenal cytochrome P450C17 in the hamster, a small animal model for the study of adrenal dehydroepiandrosterone biosynthesis. DNA Cell Biol., 16, 357–368 (1997)
Chan, F.C.; Potter, G.A.; Barrie, S.E.; Haynes, B.P.; Rowlands, M.G.; Houghton, J.; Jarman, M.: 3and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17α) (17 α-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer. J. Med. Chem., 39, 3319–3323 (1996)
Dalla Valle, L.; Ramina, A.; Vianello, S.; Belvedere, P.; Colombo, L.: Kinetic analysis of duodenal and testicular cytochrome P450cl7 in the rat. J. Steroid Biochem. Mol. Biol., 58, 577–584 (1996)
Fournet, N.; Weitsman, S.R.; Zachow, R.J.; Magoffin, D.A.: Transforming growth factor-Β inhibits ovarian 17α-hydroxylase activity by a direct noncompetitive mechanism. Endocrinology, 137, 166–174 (1996)
Potter, G.A.; Barrie, S.E.; Jarman, M.; Rowlands, M.G.: Novel steroidal inhibitors of human cytochrome P45017 a (17α-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer. J. Med. Chem., 38, 2463–2471 (1995)
Imai, T.; Globerman, H.; Gertner, J.M.; Kagawa, N.; Waterman, M.R.: Expression and purification of functional human 17 α-hydroxylase/17,20 lyase (P450cl7) in Escherichia coli. Use of this system for study of a novel form of combined 17 α-hydroxylase/17,20-lyase deficiency. J. Biol. Chem., 268, 19681–19689 (1993)
Bicikova, M.; Hampl, R.; Hill, M.; Starka, L.: Inhibition of steroid 17α-hydroxylase and C17,20-lyase in the human testis by epitestosterone. J. Steroid Biochem. Mol. Biol., 46, 515–518 (1993)
Kuwada, M.; Sone, Y.; Kitajima, R.: Purification from adult pig testicular P 450 and 17 α-hydroxylase activity of P-450 containing liposomal membranes. Biochem. Biophys. Res. Commun., 196, 816–824 (1993)
Sakaki, T.; Shibata, M.; Yabusaki, Y.; Murakami, H.; Ohkawa, H.: Genetically engineered P450 monooxygenases: construction of bovine P450cl7/yeast reductase fused enzymes. DNA Cell Biol, 9, 27–36 (1990)
Angelastro, M.R.; Laughlin, M.E.; Schatzman, G.L.; Bey, P.; Blohm, T.R.: 17Β-(Cyclopropylamino)-androst-5-en-3 Β-o,a selective mechanism-based inhibitor of cytochrome P450(17 α) (steroid 17α-hydroxylase/C17-20 lyase). Biochem. Biophys. Res. Commun., 162, 1571–1577 (1989)
Schatzman, G.L.; Laughlin, M.E.; Blohm, T.R.: A normal phase high-performance liquid chromatography system for steroid 17α-hydroxylase/C17-20 lyase (cytochrome P-45021scc) assays. Anal. Biochem., 175, 219–226 (1988)
Sheets, J.J.; Zuber, M.X.; McCarthy, J.L.; Vickery, L. E.; Waterman, M.R.: Discriminatory inhibition of adrenocortical 17α-hydroxylase activity by inhibitors of cholesterol side chain cleavage cytochrome P-450. Arch. Biochem. Biophys., 242, 297–305 (1985)
Shinzawa, K.; Kominami, S.; Takemori, S.: Studies on cytochrome P-450 (P 450 17α,lyase) from guinea pig adrenal microsomes. Dual function of a single enzyme and effect of cytochrome b5. Biochim. Biophys. Acta, 833, 151–160 (1985)
Nakajin, S.; Shinoda, M.; Haniu, M.; Shively, J.E.; Hall, P.F.: C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17 α-hydroxylase/C17,20-lyase cytochrome P-450. J. Biol. Chem., 259, 3971–3976 (1984)
Nakajin, S.; Shinoda, M.; Hall, P.F.: Purification and properties of 17α-hydroxylase from microsomes of pig adrenal: a second C21 side-chain cleavage system. Biochem. Biophys. Res. Commun., 111, 512–517 (1983)
Nakajin, S.; Shively, J.E.; Yuan, P.M.; Hall, P.F.: Microsomal cytochrome P 450 from neonatal pig testis: two enzymatic activities (17α-hydroxylase and cl7,20-lyase) associated with one protein. Biochemistry, 20, 4037–4042 (1981)
Nakajin, S.; Hall, P.F.: Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of a C21 steroid side-chain cleavage system (17α-hydroxylase-C17,20 lyase). J. Biol. Chem., 256, 3871–3876 (1981)
Fevold, H.R.; Wilson, P.L.; Slanina, S.M.: ACTH-stimulated rabbit adrenal 17α-hydroxylase. Kinetic properties and a comparison with those of 3Β-hydroxysteroid dehydrogenase. J. Steroid Biochem., 9, 1033–1041 (1978)
Fan, D.F.; Oshima, H.; Troen, B.R.; Troen, P.: Studies of the human testis. IV. Testicular 20 α-hydroxysteroid dehydrogenase and steroid 17α-hydroxylase. Biochim. Biophys. Acta, 360, 88–99 (1974)
Lynn, W.S.; Brown, R.H.: The conversion of progesterone to androgens by testes. J. Biol. Chem., 232, 1015–1031 (1958)
Namiki, M.; Kitamura, M.; Buczko, E.; Dufau, M.L.: Rat testis P-45017α cDNA: the deduced amino acid sequence, expression and secondary structural configuration. Biochem. Biophys. Res. Commun., 157, 705–712 (1988)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2006). Steroid 17α-monooxygenase. In: Schomburg, D., Schomburg, I. (eds) Springer Handbook of Enzymes. Springer Handbook of Enzymes, vol 27. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30439-8_36
Download citation
DOI: https://doi.org/10.1007/3-540-30439-8_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-26583-2
Online ISBN: 978-3-540-30439-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)